Epithelial Protective Effects of Thyroid Hormone Signaling in Fibrosis
甲状腺激素信号传导对纤维化的上皮保护作用
基本信息
- 批准号:10307633
- 负责人:
- 金额:$ 78.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-12-15 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectAgingAgonistAnatomyAntigensAntioxidantsApoptosisAutoimmune DiseasesAutophagocytosisBiogenesisBiologyBleomycinCardiacCell SurvivalCellsCharacteristicsChemical WarfareChronicDNADepositionDiagnosisDiseaseDoseEpigenetic ProcessEpithelialEpithelial CellsExhibitsExposure toExtracellular MatrixFDA approvedFibroblastsFibrosisGenerationsGenetic DiseasesGenetically Modified AnimalsGenomic InstabilityHealthHomeostasisHumanHydrogen PeroxideHypothyroidismIncidenceInjuryInterstitial Lung DiseasesKineticsLettersLongitudinal cohortLungMetabolicMetabolismMitochondriaMitochondrial DNAModelingMorphologyMusOLFM4 geneOligomycinsOrganOxidantsOxidesPINK1 genePathway interactionsPatientsPeroxisome Proliferator-Activated ReceptorsPersonsPharmaceutical PreparationsPhenotypePlasmaProcessProductionPrognosisProgressive DiseasePulmonary FibrosisRadiationReactive Oxygen SpeciesRegulationResearchResolutionRoleSecondary toSignal PathwaySliceSpecimenStructure of parenchyma of lungSystemTestingTherapeuticThyroid GlandThyroid Hormone ReceptorThyroid HormonesTissuesToxic Environmental SubstancesToxic effectTranscription Coactivatoraerosolizedalveolar epitheliumalveolar type II cellantifibrotic treatmentcell injurycontextual factorsend-stage organ failureepithelial injuryexperimental studyfibrotic lunghormonal signalsidiopathic pulmonary fibrosisimprovedinterestlung injurymitochondrial dysfunctionmortalitymultiple chronic conditionspreventprotective effectrecruitrepairedresponseresponse to injuryrestorationskeletaltelomerewound healing
项目摘要
PROJECT SUMMARY
Pulmonary fibrosis (PF) describes a condition in which the normal lung anatomy is replaced by a process of
active remodeling, deposition of extracellular matrix and dramatic changes in the phenotype of both fibroblasts
and alveolar epithelial cells, as a result of an abnormal wound healing process. This condition can be idiopathic,
as in idiopathic pulmonary fibrosis (IPF), or secondary to genetic disorders, lung parenchyma involvement in
autoimmune disorders, or to exposure to environmental toxins, chemical warfare, drugs, foreign antigens, or
radiation. IPF is the most common idiopathic form of pulmonary fibrosis that affects approximately 120,000
patients in the US with a steady increase in both incidence and mortality. 40,000 patients die from IPF each year.
More recently it has been proposed that many of the hallmarks of aging including genomic instability, telomere
attrition, epigenetic alterations, and mitochondrial dysfunction can be considered characteristic of the fibrotic
lung. Specifically, alveolar type II cells exhibit dysmorphic mitochondria, reduced energy production and
increased mitochondrial reactive oxygen species. We recently discovered that administration of thyroid hormone
late after bleomycin induced lung injury significantly enhanced the resolution of murine bleomycin-induced lung
fibrosis. We discovered that these effects were associated with induction of PPARGC1A, a transcriptional
coactivator with significant roles in regulation of metabolism, mitochondrial remodeling and mitochondrial
biogenesis. This effect was accompanied by reduced apoptosis and normalized mitochondrial morphology and
function in alveolar type II cells and was dependent on intact mitogeneration and mitophagy pathways. Finally,
in banked plasma specimens obtained from a large, well characterized longitudinal cohort of IPF patients, we
identified increased levels of circulating mitochondrial DNA that were associated with significantly increased
mortality in these patients. Considering that thyroid hormone is critically important for repair after injury through
activation of pro-survival and anti-oxidant signaling pathways and regulation of mitochondrial homeostasis and
metabolism and that hypothyroidism is associated with unfavorable prognosis in multiple chronic conditions
including IPF, we hypothesize that restoration of mitochondrial homeostasis by augmented thyroid hormone
signaling could establish a viable therapeutic strategy for epithelial protection and resolution of pulmonary
fibrosis. We will address this hypothesis by the following specific aims: Aim 1: To determine that thyroid hormone
signaling reverses cellular injury by inducing both mitogeneration and mitophagy. Aim 2: To determine how
thyroid hormone signaling induced changes in mitochondrial biology result in reduction of organ fibrosis. Aim 3:
To establish the potential utility of Sobetirome, a thyromimetic drug relatively devoid of thyroid cardiac and
skeletal toxicity, as an antifibrotic agent. Together these experiments will establish the mechanisms and rationale
for the use of augmenting thyroid hormone signaling as an antifibrotic strategy in humans.
项目摘要
肺纤维化(PF)描述了其中正常的肺解剖结构被肺纤维化过程替代的病症。
两种成纤维细胞的活性重塑、细胞外基质沉积和表型的显著变化
和肺泡上皮细胞,作为异常伤口愈合过程的结果。这种情况可能是特发性的,
如在特发性肺纤维化(IPF)中,或继发于遗传性疾病,
自身免疫性疾病,或暴露于环境毒素,化学战,药物,外来抗原,或
辐射IPF是最常见的特发性肺纤维化形式,影响约120,000例
美国患者的发病率和死亡率均稳步上升。每年有40,000名患者死于IPF。
最近有人提出,衰老的许多标志,包括基因组的不稳定性,端粒,
磨损、表观遗传改变和线粒体功能障碍可以被认为是纤维化的特征。
肺。具体地,肺泡II型细胞表现出畸形的线粒体,减少的能量产生和
线粒体活性氧增加。我们最近发现甲状腺激素的使用
博莱霉素诱导肺损伤后晚期明显增强博莱霉素诱导小鼠肺的消退
纤维化我们发现这些效应与PPARGC 1A的诱导有关,PPARGC 1A是一种转录因子,
在调节代谢、线粒体重塑和线粒体凋亡中具有重要作用的共激活因子
生物起源。这种作用伴随着细胞凋亡减少和线粒体形态正常化,
在肺泡II型细胞的功能,并依赖于完整的有丝分裂和线粒体自噬途径。最后,
在从一个大型的、充分表征的IPF患者纵向队列中获得的库存血浆标本中,我们
确定了循环线粒体DNA水平的增加,
这些患者的死亡率。考虑到甲状腺激素对损伤后的修复至关重要,
激活促存活和抗氧化信号传导途径,调节线粒体稳态,
甲状腺功能减退症与多种慢性疾病的不良预后有关
包括特发性肺纤维化,我们假设通过增加甲状腺激素恢复线粒体稳态,
信号传导可以建立一个可行的治疗策略,用于上皮保护和肺动脉高压的解决。
纤维化我们将通过以下具体目标来解决这一假设:目标1:确定甲状腺激素
信号转导通过诱导有丝分裂和线粒体自噬来逆转细胞损伤。目标2:确定如何
甲状腺激素信号传导诱导的线粒体生物学变化导致器官纤维化减少。目标三:
为了确定Sobetirome的潜在效用,Sobetirome是一种相对缺乏甲状腺心脏和
骨骼毒性,作为抗纤维化剂。这些实验将共同建立机制和原理
用于增强甲状腺激素信号传导作为人类抗纤维化策略的用途。
项目成果
期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A statistical framework to identify cell types whose genetically regulated proportions are associated with complex diseases.
- DOI:10.1371/journal.pgen.1010825
- 发表时间:2023-07
- 期刊:
- 影响因子:4.5
- 作者:
- 通讯作者:
Long noncoding RNA TINCR is a novel regulator of human bronchial epithelial cell differentiation state.
- DOI:10.14814/phy2.14727
- 发表时间:2021-03
- 期刊:
- 影响因子:2.5
- 作者:Omote N;Sakamoto K;Li Q;Schupp JC;Adams T;Ahangari F;Chioccioli M;DeIuliis G;Hashimoto N;Hasegawa Y;Kaminski N
- 通讯作者:Kaminski N
Somatic Mutations: The Next Frontier in Demystifying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis?
体细胞突变:揭开慢性阻塞性肺疾病和特发性肺纤维化神秘面纱的下一个前沿?
- DOI:10.1164/rccm.202310-1774ed
- 发表时间:2023
- 期刊:
- 影响因子:24.7
- 作者:Yan,Xiting;Kaminski,Naftali
- 通讯作者:Kaminski,Naftali
microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis.
- DOI:10.1172/jci.insight.158100
- 发表时间:2023-02-22
- 期刊:
- 影响因子:8
- 作者:Ahangari, Farida;Price, Nathan L.;Malik, Shipra;Chioccioli, Maurizio;Barnthaler, Thomas;Adams, Taylor S.;Kim, Jooyoung;Pradeep, Sai Pallavi;Ding, Shuizi;Cosmos Jr., Carlos;Rose, Kadi-Ann S.;McDonough, John E.;Aurelien, Nachelle R.;Ibarra, Gabriel;Omote, Norihito;Schupp, Jonas C.;DeIuliis, Giuseppe;Nunez, Julian A. Villalba;Sharma, Lokesh;Ryu, Changwan;Dela Cruz, Charles S.;Liu, Xinran;Prasse, Antje;Rosas, Ivan;Bahal, Raman;Fernandez-Hernando, Carlos;Kaminski, Naftali
- 通讯作者:Kaminski, Naftali
Alveolar Vascular Remodeling in Nonspecific Interstitial Pneumonia: Replacement of Normal Lung Capillaries with COL15A1-Positive Endothelial Cells.
非特异性间质性肺炎中的肺泡血管重塑:用 COL15A1 阳性内皮细胞替换正常肺毛细血管。
- DOI:10.1164/rccm.202303-0544le
- 发表时间:2023
- 期刊:
- 影响因子:24.7
- 作者:Schupp,JonasC;Manning,EdwardP;Chioccioli,Maurizio;Kamp,JanC;Christian,Leonard;Ryu,Changwan;Herzog,Erica;Kühnel,MarkP;Prasse,Antje;Kaminski,Naftali;Jonigk,DannyD;Homer,RobertJ;Yale-MHH-MGHStudyGroup
- 通讯作者:Yale-MHH-MGHStudyGroup
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAFTALI KAMINSKI其他文献
NAFTALI KAMINSKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAFTALI KAMINSKI', 18)}}的其他基金
Integrating single-cell based transcriptomic signatures for identifying therapeutic targets of COPD
整合基于单细胞的转录组特征来识别 COPD 的治疗靶点
- 批准号:
10360807 - 财政年份:2022
- 资助金额:
$ 78.81万 - 项目类别:
Integrating single-cell based transcriptomic signatures for identifying therapeutic targets of COPD
整合基于单细胞的转录组特征来识别 COPD 的治疗靶点
- 批准号:
10540331 - 财政年份:2022
- 资助金额:
$ 78.81万 - 项目类别:
Epithelial Protective Effects of Thyroid Hormone Signaling in Fibrosis
甲状腺激素信号传导对纤维化的上皮保护作用
- 批准号:
10063549 - 财政年份:2018
- 资助金额:
$ 78.81万 - 项目类别:
Mir-29 mimicry as a therapy for pulmonary fibrosis
Mir-29拟态作为肺纤维化的治疗方法
- 批准号:
8931051 - 财政年份:2014
- 资助金额:
$ 78.81万 - 项目类别:
Mir-29 mimicry as a therapy for pulmonary fibrosis
Mir-29拟态作为肺纤维化的治疗方法
- 批准号:
9144911 - 财政年份:2014
- 资助金额:
$ 78.81万 - 项目类别:
Mir-29 mimicry as a therapy for pulmonary fibrosis
Mir-29拟态作为肺纤维化的治疗方法
- 批准号:
8758509 - 财政年份:2014
- 资助金额:
$ 78.81万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 78.81万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 78.81万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 78.81万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 78.81万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 78.81万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 78.81万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 78.81万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 78.81万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 78.81万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 78.81万 - 项目类别:
Research Grant